Richard B. Stead

Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term Hemodialysis

Karl E. Anderson, Douglas E. Goeger, Richard W. Carson et al. · New England Journal of Medicine · 1990 · 375 citations

Genetics, Pathology, Dialysis Therapy +16

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia

Iain C. Macdougall, Jérôme Rossert, Nicole Casadevall et al. · New England Journal of Medicine · 2009 · 156 citations · Full text

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

Cornelis J.M. Melief, Marij J.P. Welters, Ignace Vergote et al. · Science Translational Medicine · 2020 · 126 citations · Full text

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers

Richard B. Stead, John S. Lambert, Dawie Wessels et al. · Blood · 2006 · 110 citations

Pegfilgrastim Administered in an Abbreviated Schedule, Significantly Improved Neutrophil Recovery after High-Dose Radiation-Induced Myelosuppression in Rhesus Macaques

Ann M. Farese, Melanie Cohen, Richard B. Stead et al. · Radiation Research · 2012 · 56 citations

Pegfilgrastim Administered, Immunology, Pharmacotherapy +19